EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 85 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,639,226 | +57.3% | 580,629 | +71.3% | 0.00% | +100.0% |
| Q2 2023 | $2,948,839 | +163997.9% | 338,947 | -44.5% | 0.00% | 0.0% |
| Q1 2023 | $1,797 | -24.0% | 611,178 | -9.5% | 0.00% | 0.0% |
| Q4 2022 | $2,364 | -99.9% | 675,433 | +64.6% | 0.00% | -50.0% |
| Q3 2022 | $3,245,000 | +20.1% | 410,286 | +19.5% | 0.00% | 0.0% |
| Q2 2022 | $2,701,000 | +43.2% | 343,223 | +121.1% | 0.00% | +100.0% |
| Q1 2022 | $1,886,000 | +25.1% | 155,265 | +26.0% | 0.00% | 0.0% |
| Q4 2021 | $1,508,000 | +288.7% | 123,203 | +231.2% | 0.00% | – |
| Q3 2021 | $388,000 | -91.4% | 37,203 | -92.6% | 0.00% | -100.0% |
| Q2 2021 | $4,519,000 | +52.3% | 502,671 | +72.1% | 0.00% | +50.0% |
| Q1 2021 | $2,967,000 | +1720.2% | 292,056 | +1078.4% | 0.00% | – |
| Q4 2020 | $163,000 | – | 24,784 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,490,921 | $27,892,459 | 24.59% |
| ACUTA CAPITAL PARTNERS, LLC | 300,128 | $2,398,023 | 1.61% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,492,147 | $27,902,255 | 1.51% |
| Cormorant Asset Management, LP | 3,200,000 | $25,568,000 | 1.49% |
| Samsara BioCapital, LLC | 432,000 | $3,451,680 | 1.06% |
| Ghost Tree Capital, LLC | 325,000 | $2,596,750 | 0.85% |
| RA Capital Management | 3,370,506 | $26,930,343 | 0.53% |
| Ikarian Capital, LLC | 4,487 | $3,585,113 | 0.43% |
| Affinity Asset Advisors, LLC | 155,000 | $1,238,450 | 0.35% |
| SECTORAL ASSET MANAGEMENT INC | 176,080 | $1,406,879 | 0.27% |